Cyclerion Therapeutics In... (CYCN)
NASDAQ: CYCN
· Real-Time Price · USD
2.39
0.06 (2.58%)
At close: Aug 15, 2025, 3:59 PM
2.39
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
Cyclerion Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 3.01M | 3.64M | 3.23M | 2.87M | 4.59M | 5.7M | 7.57M | 9.11M | 5.64M | 7.17M | 13.38M | 20.41M | 30.32M | 41.13M | 53.96M | 62.5M | 70.39M | 41.43M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.84M |
Other Long-Term Assets | 5.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.86M | 1.95M | 2.04M | 2.13M | 2.22M | 2.32M | 2.41M | 2.5M | 2.59M | 2.68M |
Receivables | 525K | 581K | 556K | 44K | n/a | n/a | n/a | n/a | n/a | 96K | 96K | 227K | 227K | 227K | 100K | 158K | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 567K | 805K | 536K | 647K | 1.01M | 928K | 562K | n/a | n/a |
Other Current Assets | 489K | 21K | 16K | 11K | 11K | 10K | 11K | 30K | 428K | 503K | 537K | 488K | 482K | 477K | 468K | 459K | 1.83M | 1.8M |
Total Current Assets | 4.02M | 4.5M | 4.22M | 3.55M | 4.71M | 6.01M | 8.02M | 9.86M | 7.11M | 8.34M | 14.82M | 21.66M | 31.68M | 42.84M | 55.46M | 63.68M | 72.99M | 44.45M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.13M | 1.17M | 1.22M | 1.26M | 1.31M | 1.37M | 1.47M | 1.56M | 153K | 49M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 2.98M | 3.12M | 3.26M | 3.4M | 3.53M | 3.69M | 3.87M | 4.06M | 2.74M | 55.52M |
Total Assets | 9.37M | 9.85M | 9.57M | 8.9M | 10.06M | 11.36M | 13.37M | 15.21M | 10.1M | 11.46M | 18.08M | 25.05M | 35.21M | 46.52M | 59.33M | 67.74M | 75.73M | 99.97M |
Account Payables | 462K | 483K | 390K | 304K | 651K | 741K | 1.2M | 814K | 1.86M | 3.92M | 2.97M | 1.65M | 2.77M | 2.52M | 1.83M | 1.17M | 1.39M | 1.09M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.84M | 5.39M | 5.1M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.51M | 3.51M | 3.51M |
Other Current Liabilities | 338K | 45K | 63K | 396K | 616K | 678K | 102K | 1.5M | 2.56M | 2.81M | 3.99M | 5.15M | 5.51M | 5.63M | 7.28M | 4.93M | 4.07M | 4.3M |
Total Current Liabilities | 800K | 1.07M | 725K | 700K | 1.28M | 1.44M | 2.09M | 2.34M | 4.95M | 7.53M | 7.63M | 8.53M | 9.85M | 9.49M | 11.09M | 11.36M | 10.51M | 13.47M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.92M | 2.97M | 1.65M | 2.77M | 2.52M | 1.83M | n/a | n/a | 38.07M |
Total Liabilities | 800K | 1.07M | 725K | 700K | 1.28M | 1.44M | 2.09M | 2.34M | 4.95M | 7.53M | 7.63M | 8.53M | 9.85M | 9.49M | 11.09M | 11.36M | 10.51M | 51.53M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.51M | 3.51M | 44.96M |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -269.25M | -268.92M | -267.49M | -268.02M | -267.3M | -265.96M | -264.42M | -262.72M | -270.29M | -266.11M | -259.15M | -251.94M | -241.44M | -228.05M | -215.08M | -204.3M | -193.01M | -176.83M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | -16K | -12K | -18K | -16K | -19K | -20K | -28K | -25K | -24K | -23K | -26K | -26K | -27K |
Shareholders Equity | 8.57M | 8.78M | 8.85M | 8.2M | 8.78M | 9.92M | 11.29M | 12.87M | 5.15M | 3.92M | 10.45M | 16.52M | 25.36M | 37.03M | 48.25M | 56.39M | 65.22M | 48.43M |
Total Investments | n/a | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.84M |